You are here » Home » Companies » Company Overview » Unicorn Pharmaceuticals (India) Ltd

Unicorn Pharmaceuticals (India) Ltd.

BSE: 524334 Sector: Health care
NSE: N.A. ISIN Code: N.A.
BSE LIVE 05:30 | 01 Jan Stock Is Not Traded.
NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN
PREVIOUS CLOSE
VOLUME
52-Week high 0.00
52-Week low 0.00
P/E
Mkt Cap.(Rs cr) 0
Buy Price
Buy Qty
Sell Price
Sell Qty
OPEN
CLOSE
VOLUME
52-Week high 0.00
52-Week low 0.00
P/E
Mkt Cap.(Rs cr) 0
Buy Price
Buy Qty
Sell Price
Sell Qty

Unicorn Pharmaceuticals (India) Ltd. (UNICORNPHARMA) - Auditors Report

Company auditors report

1994 UNICORN PHARMACEUTICALS (INDIA) LIMITED AUDITORS' REPORT TO THE MEMBERS We have audited the attached Balance Sheet of M/s. Unicorn Pharmaceuticals (India) Limited as at 30th, September, 1994 and also the Profit and Loss Account/Pre-operative. Expenses for the period ended on that date annexed thereto and report that: (a) we have obtained all the information and explanations which to the best of our knowledge and belief were necessary for the purpose of our audit. (b) in our opinion, proper books of accounts as required by law, have been kept by the Company, so far as appears from our examination of the books. (c) the Balance Sheet and the Profit and Loss Account dealt with by this report are in agreement with the books of account. (d) in our opinion and to the best of our information and according to the explanations given to us, the said accounts together with the notes thereon, give the information required by the Companies Act, 1956, in the manner so required and also give a true and fair view:- (i) in case of the Balance Sheet, of state of affairs of the Company as at 30th September, 1994; and (ii) in case of the Profit and Loss Account, of the Profit of the Company for the period ended on that date. for J.S.S. ASSOCIATES Chartered Accountants Madras V. SRIDHAR 16.11.94. Partner